Ligand Pharmaceuticals
LGND
LGND
326 hedge funds and large institutions have $4.09B invested in Ligand Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 60 funds opening new positions, 96 increasing their positions, 128 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.16% more ownership
Funds ownership: 187.52% → 187.67% (+0.16%)
25% less call options, than puts
Call options by funds: $9.61M | Put options by funds: $12.8M
25% less repeat investments, than reductions
Existing positions increased: 96 | Existing positions reduced: 128
Holders
326
Holding in Top 10
12
Calls
$9.61M
Puts
$12.8M
Top Buyers
| 1 | +$60.3M | |
| 2 | +$52M | |
| 3 | +$33.2M | |
| 4 |
Two Sigma Investments
New York
|
+$24.7M |
| 5 |
Two Sigma Advisers
New York
|
+$22.8M |
Top Sellers
| 1 | -$35.5M | |
| 2 | -$34.8M | |
| 3 | -$34.7M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$29.7M |
| 5 |
CLM
ClearBridge LLC (Maryland)
Baltimore,
Maryland
|
-$18.3M |